Skip to main navigation Skip to search Skip to main content

A Phase III Trial Of Novel Epothilone BMS-24550 Plus Capecitabine Versus Capecitabine Alone In Patients With Advanced Breast Cancer Previously Treated With An Anthracycline And A Taxane

  • Poole, Christopher (Principal Investigator)

Project Details

Short titleA Phase III Trial Of Novel Epothilone BMS-24550 Plus Capecitabine Versus Capecitabine Alone In Patients With Advanced Breast Cancer Previously Treated With An Anthracycline And A Taxane
StatusFinished
Effective start/end date1/08/04 → 31/07/07

Funding

  • Bristol Myers Squibb Pharmaceuticals